VRNA — Verona Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Verona Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	188	148	228	272	400
Net Total Accounts Receivable
Net Total Receivables	8.26	15.6	9.28	11	37.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	203	170	243	290	454
Net Property, Plant And Equipment	1.16	0.979	0.927	2.87	3.15
Net Goodwill
Long Term Investments
Other Long Term Assets
Total Assets	204	187	259	308	474
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.2	33.4	19	8.69	42.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.4	38.6	29	58.8	270
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	185	148	230	249	205
Total Liabilities & Shareholders' Equity	204	187	259	308	474
Total Common Shares Outstanding